VUAB Pharma

VUAB Pharma is a prominent Czech pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Established in 1949, the company has built a global reputation as a leading manufacturer of Nystatin, an essential antifungal medication. Its portfolio also includes a robust range of oncology products, specifically platinum-based cytostatics such as Cisplatin, Carboplatin, and Oxaliplatin, as well as the hormone Oxytocin. VUAB Pharma operates as a Contract Development and Manufacturing Organization (CDMO), leveraging its expertise in both biotechnological fermentation and chemical synthesis. The company is a member of the SAFICHEM GROUP and maintains high quality standards with certifications from the FDA and other international regulatory agencies.